Journal Article

The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours

K. Last, L. Maharaj, J. Perry, S. Strauss, J. Fitzgibbon, T. A. Lister and S. Joel

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 17, issue 5, pages 773-779
Published in print May 2006 | ISSN: 0923-7534
Published online February 2006 | e-ISSN: 1569-8041 | DOI:
The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours

Show Summary Details


Background: Diffuse large B-cell lymphoma patients with low serum selenium concentration at presentation have a lower response rate and overall survival than patients with higher serum selenium. The co-administration of selenium with conventional chemotherapy may be useful in these patients.

Patients and methods: We investigated the activity of two selenium species, methylseleninic acid (MSA) and selenodiglutathione (SDG) in a panel of human lymphoma cell lines and in a primary lymphoma culture system.

Results: Both compounds demonstrated cytostatic and cytotoxic activity with EC50 values in the range 1.0–10.2 μM. Cell death was associated with an increase in the sub-G1 (apoptotic) fraction by flow cytometry and was not preceded by any obvious cell cycle arrest. SDG, but not MSA, resulted in marked increases in intracellular ROS, particularly in CRL2261 and SUD4 cells in which the cytotoxic activity of SDG was partly, or completely, inhibited by n-acetyl cysteine, suggesting a dependence on ROS for activity in some cells. Both MSA and SDG showed a concentration dependent reduction in percentage viability after a 2-day exposure in primary lymphoma cultures, with EC50 values in the range 39–300 μM and 9–28 μM, respectively.

Conclusion: The selenium compounds MSA and SDG induce cell death in lymphoma cell lines and primary lymphoma cultures, which with SDG may be partly attributable to the generation of ROS.

Keywords: lymphoma; methyseleninic acid; primary culture; selenium; selenodiglutathione

Journal Article.  4027 words.  Illustrated.

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.